Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results

View ORCID ProfileRu Han, Clément François, Mondher Toumi
doi: https://doi.org/10.1101/2020.06.22.20135434
Ru Han
1University of Aix-Marseille, Marseille, France
2Creativ-Ceutical, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ru Han
  • For correspondence: rha{at}creativ-ceutical.com
Clément François
1University of Aix-Marseille, Marseille, France
2Creativ-Ceutical, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mondher Toumi
1University of Aix-Marseille, Marseille, France
2Creativ-Ceutical, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: June 2020 to June 2025

AbstractFullPdf
Jun 2020121023
Jul 202076054
Aug 202067087
Sep 202040028
Oct 202029022
Nov 202022015
Dec 202012016
Jan 202126015
Feb 202136130
Mar 202140220
Apr 202156034
May 202145324
Jun 202145218
Jul 202117314
Aug 202117414
Sep 202127111
Oct 202114026
Nov 202115244
Dec 202129015
Jan 20221256
Feb 2022905
Mar 20221408
Apr 202212212
May 202213017
Jun 20221605
Jul 20221304
Aug 20222024
Sep 20222208
Oct 20222008
Nov 20221408
Dec 202217315
Jan 20231436
Feb 2023716
Mar 20236410
Apr 202323211
May 2023719
Jun 2023854
Jul 2023302
Aug 202314137
Sep 2023943
Oct 2023801
Nov 2023914
Dec 2023702
Jan 2024504
Feb 2024502
Mar 20241235
Apr 2024535
May 2024417
Jun 2024604
Jul 2024805
Aug 20248216
Sep 202412414
Oct 20241659
Nov 20249017
Dec 2024506
Jan 2025515
Feb 20256209
Mar 2025132623
Apr 202514319
May 202511614
Jun 2025634
Back to top
PreviousNext
Posted June 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results
Ru Han, Clément François, Mondher Toumi
medRxiv 2020.06.22.20135434; doi: https://doi.org/10.1101/2020.06.22.20135434
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results
Ru Han, Clément François, Mondher Toumi
medRxiv 2020.06.22.20135434; doi: https://doi.org/10.1101/2020.06.22.20135434

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Economics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)